Featured

A new potential treatment for schizophrenia discovered through the Warren Center for Neuroscience Drug Discovery at Vanderbilt University has entered phase 1 clinical trials, marking the fifth WCNDD therapeutic to advance into human testing. Read More

In a heartwarming tribute to a remarkable career, more than 70 of his former graduate students and postdoctoral scholars recently traveled from across the globe for a three-day festivity on Oct. 3–5 to celebrate Larry Marnett’s 50 years in academia. Read More

Vanderbilt’s Dr. Benjamin P. Brown is improving the way the field of drug discovery creates machine learning algorithms to predict a protein’s interactions with a small molecule. These improvements bring ML closer to fulfilling its potential in the field—something that has not been realized after more than a decade of work. Read More

Started in June 2025, a new collaborative science project called diffUSE involving Vanderbilt University, Cornell University, and the University of California, San Francisco, could be the next watershed moment. The $5 million, three-year project led by the Astera Institute will advance our understanding of protein motion. Using diffuse scattering, an overlooked signal measured by X-ray crystallography, the project will determine how protein dynamics are characterized, leading to a new paradigm in dynamic structural biology. Read More

The Vanderbilt University School of Medicine Basic Sciences welcomed 42 new graduate students into its Interdisciplinary Graduate Program and Quantitative and Chemical Biology Program through orientation events and the Simple Beginnings ceremony. These academic programs combine coursework and research to guide students toward earning a Ph.D. and careers in the biomedical sciences. Read More

A colorectal cancer research team led by Robert Coffey has received a Specialized Programs of Research Excellence grant renewal totaling $12.6 million from the National Cancer Institute.The team has made numerous discoveries over the past 23 years, and it plans to build upon those achievements with the goal of “drugging the undruggable.” Vanderbilt-Ingram is one of only four cancer centers in the U.S. with GI Cancer SPORE funding. Read More

David Cortez and Rahul Bhowmick won the Chancellor’s Award for Research for their work, “RAD51 Bypasses the CMG Helicase to Promote Replication Fork Reversal,” which was published in the journal Science. Read More

James Hayes, Rekha Nagarajan, and James Costanzo are the winners of the 2025 Cell Imaging Shared Resource Life Is Beautiful image contest. CISR provides researchers with access to state-of-the-art imaging equipment and expert technical support for sophisticated microscopy and analysis of tissue and cellular anatomy and physiology. Read More

Scott Hiebert, Hortense B. Ingram Chair in Cancer Research, has been named Chief Scientific Officer of the  Cancer Prevention and Research Institute of Texas. Hiebert served as chair of the National Cancer Advisory Board and brought global recognition to the Vanderbilt-Ingram Cancer Center during his 28 years at Vanderbilt. Read More